Literature DB >> 17627810

Kaposi's sarcoma herpesvirus load in biopsies of cutaneous and oral Kaposi's sarcoma lesions.

Fatemeh Pak1, Amos R Mwakigonja, Parviz Kokhaei, Nahid Hosseinzadeh, Pawan Pyakurel, Ephata Kaaya, Gordana Bogdanovic, Galina Selivanova, Peter Biberfeld.   

Abstract

OBJECTIVES: To evaluate human herpesvirus 8/Kaposi's sarcoma associated herpesvirus (HHV-8/KSHV) viral load in diagnostic, (formalin fixed, paraffinised) biopsies and patient serum during tumour progression of oral and cutaneous AIDS-related Kaposi's sarcoma (AKS), and endemic Kaposi's sarcoma (EKS) by a sensitive and specific quantitative real time polymerase chain reaction (qRT-PCR) assay. STUDY
DESIGN: Eighty six biopsies of both AKS (oral and cutaneous AKS, 68) and EKS (cutaneous EKS, 18) were evaluated by qRT-PCR and immunohistochemistry (IHC). The viral load in human tumour tissue and serum of some individual patients were compared.
RESULTS: Higher viral load as well as frequency of latency-associated nuclear antigen (LANA)+ tumour spindle cells (SC) and number of LANA granules per SC was found in oral AKS compared to cutaneous AKS. Although few cases were available, serum viral load appeared to decrease compared to tumour tissue during KS progression.
CONCLUSIONS: The higher viral load in oral rather than cutaneous AKS is consistent with the well recognised reservoir function of the oral mucosa. Decrease of serum HHV-8 load during KS progression may indicate decreased virus release and/or increased virus clearance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627810     DOI: 10.1016/j.ejca.2007.05.023

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Oral Kaposi Sarcoma in two patients living with HIV despite sustained viral suppression: New clues.

Authors:  Clement Messeca; Matthieu Balanger; Florent Geoffroy; Xavier Duval; Mahtab Samimi; Sarah Millot
Journal:  J Clin Exp Dent       Date:  2022-05-01

2.  Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).

Authors:  Lia Koski; Twalib Ngoma; Julius Mwaiselage; Lynne Le; Amr S Soliman
Journal:  Int J STD AIDS       Date:  2014-07-30       Impact factor: 1.359

3.  LANA-1, Bcl-2, Mcl-1 and HIF-1alpha protein expression in HIV-associated Kaposi sarcoma.

Authors:  E Long; M Ilie; V Hofman; K Havet; E Selva; C Butori; J P Lacour; A M Nelson; G Cathomas; P Hofman
Journal:  Virchows Arch       Date:  2009-05-30       Impact factor: 4.064

4.  KSHV/HHV-8 and HIV infection in Kaposi's sarcoma development.

Authors:  Pawan Pyakurel; Fatemeh Pak; Amos R Mwakigonja; Ephata Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2007-02-02       Impact factor: 2.965

5.  Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Authors:  Amos R Mwakigonja; Pawan Pyakurel; Parviz Kokhaei; Fatemeh Pak; Leonard K Lema; Ephata E Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2008-06-30       Impact factor: 2.965

6.  Oral HIV-Associated Kaposi Sarcoma: A Clinical Study from the Ga-Rankuwa Area, South Africa.

Authors:  Razia A G Khammissa; Liron Pantanowitz; Liviu Feller
Journal:  AIDS Res Treat       Date:  2012-09-12

7.  Detection of human herpesvirus 8 by quantitative polymerase chain reaction: development and standardisation of methods.

Authors:  David J Speicher; Newell W Johnson
Journal:  BMC Infect Dis       Date:  2012-09-11       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.